Predictive immune markers in advanced melanoma patients treated with ipilimumab.
about
Intercellular crosstalk in human malignant melanoma.Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein.Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab.Eosinophils: The unsung heroes in cancer?SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma.
P2860
Predictive immune markers in advanced melanoma patients treated with ipilimumab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Predictive immune markers in advanced melanoma patients treated with ipilimumab.
@en
Predictive immune markers in advanced melanoma patients treated with ipilimumab.
@nl
type
label
Predictive immune markers in advanced melanoma patients treated with ipilimumab.
@en
Predictive immune markers in advanced melanoma patients treated with ipilimumab.
@nl
prefLabel
Predictive immune markers in advanced melanoma patients treated with ipilimumab.
@en
Predictive immune markers in advanced melanoma patients treated with ipilimumab.
@nl
P2860
P1433
P1476
Predictive immune markers in advanced melanoma patients treated with ipilimumab.
@en
P2093
Viktor Umansky
P2860
P304
P356
10.1080/2162402X.2016.1158901
P577
2016-04-29T00:00:00Z